Why Is Keppra So Hard to Find? [Explained for 2026]

If you've ever arrived at your pharmacy only to be told that Keppra — or its generic, levetiracetam — is out of stock, you know how frightening that moment can be. For people managing epilepsy, missing even a single dose can have serious consequences, including breakthrough seizures. So why does this keep happening, and what can patients do about it in 2026?

Is Keppra Actually in Shortage?

As of early 2026, Keppra (levetiracetam) is not listed on the FDA's official drug shortage database. Unlike some medications — such as certain ADHD drugs or GLP-1 injectables — levetiracetam is not subject to DEA manufacturing quotas and has multiple generic manufacturers producing it. This generally means the overall supply is stable at the national level.

However, "no national shortage" doesn't mean "available at every pharmacy." What patients experience are localized stock gaps — situations where a specific pharmacy in your area happens to be out of the particular strength or formulation you need. A 2024 survey of epilepsy patients in the UK found that 62.8% reported difficulty obtaining levetiracetam at some point, even when no official shortage existed. Similar localized gaps occur in the United States.

What Causes Localized Stock Gaps for Keppra?

Several factors can make it hard to find levetiracetam at your local pharmacy:

Just-in-time inventory: Large pharmacy chains order medications in small, frequent batches. If there's a brief disruption in the supply chain, shelves can empty before the next order arrives.

Multiple generic manufacturers: While having multiple manufacturers is generally good for supply, pharmacies often only stock one generic brand at a time. If that specific manufacturer has a production delay, your pharmacy runs out even if other generics exist.

Specific strength shortages: Not all tablet strengths (250 mg, 500 mg, 750 mg, 1000 mg) are always available simultaneously. A pharmacy may have 500 mg but not 250 mg, making it impossible to fill your exact prescription.

High demand: Levetiracetam was the 101st most prescribed drug in the United States in 2023, with more than 6 million prescriptions filled. High demand means high turnover, and high turnover means stock can deplete quickly.

Extended-release formulations: Keppra XR (extended-release) tablets are stocked less consistently than immediate-release tablets. If you take Keppra XR, you may face more difficulty than those on immediate-release.

Is It Dangerous to Miss a Dose of Keppra?

Yes — and this is what makes levetiracetam availability so critical. Keppra is an anti-seizure medication, and abrupt discontinuation or missed doses can trigger breakthrough seizures in people who have been seizure-free. The FDA label explicitly warns that Keppra must be gradually withdrawn under medical supervision. If you are running low and cannot fill your prescription, contact your neurologist or prescriber immediately — do not simply stop taking the medication.

Why Does the Brand Keppra Cost So Much More Than Generic?

Brand-name Keppra (manufactured by UCB Pharmaceuticals) costs approximately $810 for 60 tablets (500 mg) without insurance. Generic levetiracetam retails for about $65 at most pharmacies, and can be had for as little as $6–$7 with a GoodRx or SingleCare coupon. This enormous price gap exists because brand-name drugs carry the cost of original research and development, while generics only cover manufacturing.

Most insurance plans and Medicare cover the generic but not the brand. If your pharmacy is out of the specific generic manufactured by one company, ask whether they can order a different generic manufacturer's version — they often can.

What Can You Do When You Can't Find Keppra?

If your usual pharmacy is out of stock, here are actionable steps to take:

Call multiple pharmacies. Don't just check one. Independent pharmacies, grocery store pharmacies, and large chains all carry different stock.

Use medfinder.[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop calls pharmacies near you to check who has your medication in stock, saving you hours of frustrating phone calls.

Ask about a different strength combination. If your dose is 1000 mg twice daily and 1000 mg tablets are unavailable, ask your pharmacist whether two 500 mg tablets can be substituted (with physician approval).

Ask about the oral solution. The 100 mg/mL grape-flavored liquid formulation may be available even when tablets are out.

Contact your neurologist. They may be able to provide samples, contact a specialty pharmacy, or adjust your prescription temporarily.

Will This Problem Get Worse?

The U.S. levetiracetam supply is generally stable going into 2026, with no active FDA shortage. But the drug's widespread use — more than 6 million annual prescriptions — means any manufacturing disruption by even one major generic supplier can create visible shortages at the retail level. Patients should fill prescriptions a few days early when possible, and maintain open communication with their neurologist about supply concerns.

For the latest on supply and what to tell your doctor, read our Keppra shortage update for patients. And if you're struggling to locate your medication right now, [@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop can help you find pharmacies near you that have Keppra in stock.